









Markets
/
Stocks
/
nasdaq-ydes
/

YD Bio Ord Shs

YDES

15.420

+1.515+10.90%

Close 12/08, 16:00（ET）Quotes delayed by 15 min

--Market Cap

--P/E TTM



YD Bio Ord Shs

15.420

+1.515+10.90%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

You can check out the annual or quarterly balance sheets of YD Bio Ord Shs here to evaluate the financial health, analyze fundamentals, and calculate key ratios for liquidity, leverage, and return on equity.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q2

Total equity

Cash, cash equivalents and short-term investments

--489.71K

- Cash and cash equivalents

--469.52K

-Short-term investments

--20.19K

Receivables

--386.69K

-Accounts and notes receivable

--167.07K

Inventory

--373.52K

Prepaid expenses

--146.93K

Total current assets

--1.40M

Non-current assets

Net Fixed Assets

--83.83K

-Fixed Assets

--112.13K

-Accumulated depreciation

--28.31K

Goodwill and other intangible assets

--2.90M

Other non-current assets

--1.46M

Total non-current assets

--4.44M

Total assets

--5.84M

Liabilities

Current liabilities

-Other payables

--2.29K

Accrued expenses

--591.90K

Short-term debt and lease liabilities

--63.74K

Deferred liabilities

--39.42K

Other current liabilities

--41.71K

Total current liabilities

--752.93K

Non-current liabilities

Long-term debt and lease liabilities

--0.00

-Long-term lease liabilities

--0.00

Long-term accrued expenses

--0.00

Total non-current liabilities

--0.00

Total liabilities

--752.93K

Shareholders' equity

Common equity

--8.47M

Retained earnings

---3.38M

Capital reserves

--8.33M

Total equity

--5.09M

Currency unit

USD

Audit opinions

FAQs

What is the balance sheet?



It is a financial report that summarises the assets, liabilities, and shareholders’ equity of a company at a specific point in time.

KeyAI

